ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus
Phase 1
Completed
- Conditions
- Viral Infection
- Interventions
- Biological: Multivirus-specific T cells Dose Level 2Biological: Multivirus-specific T cells Dose Level 1Biological: Multivirus-specific T cells Dose Level 3
- First Posted Date
- 2012-04-04
- Last Posted Date
- 2019-05-30
- Lead Sponsor
- AlloVir
- Target Recruit Count
- 21
- Registration Number
- NCT01570283
- Locations
- 🇺🇸
Texas Children's Hospital, Houston, Texas, United States
🇺🇸Houston Methodist Hospital, Houston, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath